Education
About Us
Working with TipRanks
Follow Us
BrightSpring Health Services, Inc. (BTSG)
NASDAQ:BTSG
BTSG Stock Chart & Stats
$38.62
-$0.12(-0.69%)
At close: 4:00 PM EST
$38.62
-$0.12(-0.69%)
Day’s Range― - ―
52-Week Range$15.48 - $41.03
Previous CloseN/A
Volume351.53K
Average Volume (3M)4.71M
Market Cap
$7.04B
Enterprise Value$8.57B
Total Cash (Recent Filing)$140.34M
Total Debt (Recent Filing)$2.70B
Price to Earnings (P/E)64.5
Beta1.06
Next Earnings
Feb 26, 2026EPS Estimate
0.35Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.30
Shares Outstanding180,352,300
10 Day Avg. Volume4,742,774
30 Day Avg. Volume4,710,325
Financial Highlights & Ratios
PEG Ratio2.03
Price to Book (P/B)1.99
Price to Sales (P/S)0.29
P/FCF Ratio-57.52
Enterprise Value/Market Cap1.22
Enterprise Value/Revenue0.69
Enterprise Value/Gross Profit5.61
Enterprise Value/Ebitda19.23
Forecast
1Y Price Target
$43.20Price Target Upside11.86% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering12
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Generic Conversions And Margin ImprovementPlanned generic conversions and higher generic utilization are positioned to lift gross margins and sustain EBITDA growth by shifting volume to higher-profit pharmacy sales.
Limited-distribution Drug WinsOnco360's strong track record of winning limited-distribution oncology drugs can materially expand specialty pharmacy revenue and strengthen market share in high-value therapies.
Provider Services Expansion And M&A OptionalityGrowth in the higher-margin Provider Services segment, combined with balance sheet capacity for accretive acquisitions, provides diversification and supports a premium growth profile.
Bears Say
Home Health Rate Recoupment And Regulatory RiskUncertainty around the size of home health rate recoupment creates regulatory risk that may deter acquisitions and constrain near-term growth plans.
Infusion Cost ManagementWeak cost control in the infusion business, despite healthy top-line trends, could erode profitability until standardization and scalable efficiencies are achieved.
Prescription Volume Impact From Divestitures And ExitsReductions in prescription counts driven by divestitures and certain customer exits may dampen revenue momentum and complicate performance comparisons.
BrightSpring Health Services, Inc. News
BTSG FAQ
What was BrightSpring Health Services, Inc.’s price range in the past 12 months?
BrightSpring Health Services, Inc. lowest stock price was $15.48 and its highest was $41.03 in the past 12 months.
What is BrightSpring Health Services, Inc.’s market cap?
BrightSpring Health Services, Inc.’s market cap is $7.04B.
When is BrightSpring Health Services, Inc.’s upcoming earnings report date?
BrightSpring Health Services, Inc.’s upcoming earnings report date is Feb 26, 2026 which is in 42 days.
How were BrightSpring Health Services, Inc.’s earnings last quarter?
BrightSpring Health Services, Inc. released its earnings results on Oct 28, 2025. The company reported $0.3 earnings per share for the quarter, beating the consensus estimate of $0.248 by $0.052.
Is BrightSpring Health Services, Inc. overvalued?
According to Wall Street analysts BrightSpring Health Services, Inc.’s price is currently Undervalued.
Does BrightSpring Health Services, Inc. pay dividends?
BrightSpring Health Services, Inc. does not currently pay dividends.
What is BrightSpring Health Services, Inc.’s EPS estimate?
BrightSpring Health Services, Inc.’s EPS estimate is 0.35.
How many shares outstanding does BrightSpring Health Services, Inc. have?
BrightSpring Health Services, Inc. has 180,352,300 shares outstanding.
What happened to BrightSpring Health Services, Inc.’s price movement after its last earnings report?
BrightSpring Health Services, Inc. reported an EPS of $0.3 in its last earnings report, beating expectations of $0.248. Following the earnings report the stock price went up 0.147%.
Which hedge fund is a major shareholder of BrightSpring Health Services, Inc.?
Currently, no hedge funds are holding shares in BTSG
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
BrightSpring Health Services, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$43.20 (11.86% Upside)
$43.20 (11.86% Upside)
Hedge Fund Trend
Decreased
By 747.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $856.1M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 4.7%
Last 30 Days ▲ 0.2%
Last 30 Days ▲ 0.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
94.14%
12-Months-Change
Fundamentals
Return on Equity
4.25%
Trailing 12-Months
Asset Growth
4.55%
Trailing 12-Months
Company Description
BrightSpring Health Services, Inc.
BrightSpring Health Services, Inc. operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It serves patients through clinical providers and pharmacists. BrightSpring Health Services, Inc. was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. The company was founded in 1974 and is based in Louisville, Kentucky.
BTSG Company Deck
BTSG Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected strong financial performance, with significant revenue and EBITDA growth across segments, especially in Pharmacy Solutions and Provider Services. The company successfully launched new therapies in Specialty Pharmacy and reported high patient satisfaction. However, challenges such as flat EBITDA margins, home health rate concerns, and a customer bankruptcy were noted. Overall, the positive aspects outweighed the negative, indicating a strong outlook.View all BTSG earnings summariesBTSG Stock 12 Month Forecast
Average Price Target
$43.20
▲(11.86% Upside)
Technical Analysis
Ownership Overview
Currently, No data available
---